Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
International journal of sports medicine • 2004 | View Paper
“The reuptake inhibitors, nomifensine, dichlofensine and amphetamine , in the presence of pargyline , a monoamine oxidase inhibitor, stimulated both basal and K(+)-evoked release of DA from the SME and PP under static incubation conditions.”
British journal of pharmacology • 1979 | View Paper
“ Pargyline was less effective in potentiating the stimulant actions of amphetamine , and had no significant effect on the disappearance of amphetamine from the brain.”
European journal of pharmacology • 1971 | View Paper
“Nialamide, pargyline and tranylcypromine, three monoamine oxidase inhibiting drugs, and the microsomal enzyme inhibitor SKF 525‐A significantly decreased the amount of amphetamine removed from the portal circulation of the isolated perfused liver of the cat.”
The Journal of pharmacy and pharmacology • 1970 | View Paper
“The degree of potentiation of amphetamine toxicity by monoamine oxidase inhibitors varied from one to another, the range being from pargyline , which increased the toxicity of amphetamine about 3-fold, to mebanazine which increased it about 100-fold.”
European journal of pharmacology • 1969 | View Paper
“Injection of amphetamine (2 mg), but not Cholecystokinin octapeptide, in rats pretreated with pargyline increased the concentration of 3‐methoxytyramine in the dorsal striatum and this effect was blocked by pretreatment with α‐methyl‐ρ‐tyrosine.”